Evidence map›Paper›PMID 28986512›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2018

Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study of

Michael S Hofman, Peter Eu, Price Jackson, Emily Hong, David Binns, Amir Iravani, Declan Murphy, Catherine Mitchell, Shankar Siva, Rodney J Hicks and 3 more

Open access · bronzeAbstract readClinical Trial, Phase I
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Article
  3. [RSC chemical biology · 2024
    Article
  4. Article
  5. Radiometal chelators for infection diagnostics.Frontiers in nuclear medicine · 2023
    Article
  6. Review
  7. Inorganic chemistry · 2022
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Dosimetry and optimal scan time of [European journal of nuclear medicine and molecular imaging · 2021
    Article
  13. Review
  14. Pharmaceutics · 2021
    Article
  15. [Bioconjugate chemistry · 2021
    Article
  16. Article
  17. The chemical tool-kit for molecular imaging with radionuclides in the age of targeted and immune therapy.Cancer imaging : the official publication of the International Cancer Imaging Society · 2021
    Review
  18. Article
  19. The management impact ofEuropean journal of nuclear medicine and molecular imaging · 2020
    Article
  20. Manipulating the In Vivo Behaviour ofInternational journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Michael S HofmanSir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia michael.hofman@petermac.org.
Peter EuSir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
Price JacksonMedical Physics, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Emily HongCancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
David BinnsCancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Amir IravaniCancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Declan MurphyUro-Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Catherine MitchellHistopathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Shankar SivaSir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
Rodney J HicksSir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
Jennifer D YoungDivision of Imaging Sciences and Biomedical Engineering, Kings College London, London, United Kingdom; and.
Philip J BlowerDivision of Imaging Sciences and Biomedical Engineering, Kings College London, London, United Kingdom; and.
Gregory E MullenDivision of Imaging Sciences and Biomedical Engineering, Kings College London, London, United Kingdom; and.
Peter MacCallum Cancer Centre · AUKing's College London · GBUniversity of Melbourne · AUKing's College - North Carolina · US

Funding

Wellcome Trust 212885
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gallium RadioisotopesAgedAntigens, SurfaceCohort StudiesGlutamate Carboxypeptidase IIHumansMaleMiddle AgedPositron Emission Tomography Computed TomographyProstatic NeoplasmsPyridinesAntigens, SurfaceFOLH1 protein, humanGallium-68Gallium RadioisotopesGlutamate Carboxypeptidase IIhydroxypyridinesPyridines68GaPET/CTprostate cancerprostate-specific membrane antigen

Identifiers

PMID28986512
PMCPMC7116766
OpenAlexW2763304791

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.